Gu, Juan-Li
GlaxoSmithKline (United States)
2 papers on CoChat
Most cited papers
- Verified
In Vivo Myocardial Protection From Ischemia/Reperfusion Injury by the Peroxisome Proliferator–Activated Receptor-γ Agonist Rosiglitazone
Yue, T.-L., Chen, J., Bao, W., Narayanan, P. K., Bril, A., Jiang, W., Lysko, P. G., Gu, J.-L., Boyce, R., Zimmerman, D. M., et al. (2001) · Circulation
Cardiac Ischemia and ReperfusionPeroxisome Proliferator-Activated Receptors
Cited by 295
- Verified
Rosiglitazone Treatment in Zucker Diabetic Fatty Rats Is Associated With Ameliorated Cardiac Insulin Resistance and Protection From Ischemia/Reperfusion-Induced Myocardial Injury
Yue, T.-L., Bao, W., Gu, J.-L., Cui, J., Tao, L., Ma, X.-L., Ohlstein, E. H., & Jucker, B. M. (2005) · Diabetes
Cardiac Ischemia and ReperfusionCardiovascular Function and Risk Factors
Cited by 170
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free